Posts by tayloranne
StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening
StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening By StemExpress January 16, 2023 StemExpress has published its full Clinical Commercial Solutions Guide and launched their new Clinical Donor Screening services. Now, researchers and therapeutic developers can discover how StemExpress is utilizing a nationwide & coast-to-coast footprint of privately owned and operated collection facilities to support the…
For More InformationStemExpress Launches CellsExpress Bulk Cell Isolation
StemExpress Launches CellsExpress Bulk Cell Isolation Researchers can maximize their isolated cell output, saving valuable time and budget better spent on their research. FOLSOM, Calif. , /PRNewswire/ — As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk…
For More InformationISCT Meeting
ISCT Meeting 2022 May 4-7, 2022 StemExpress is excited to attend the ISCT Meeting, May 4-7, 2022, where we will join the leaders in cell and gene therapy to discuss the future of clinical research. As more commercial therapies are moving to approval stages, the need for clinical-level partners to support these projects is at…
For More InformationISSCR Annual Meeting 2022
April 15-18, 2022 San Francisco, CA StemExpress is excited to attend the ISSCR Annual Meeting, April 15-18, 2022, where we will discuss process acceleration in the development of life-saving therapies, from R&D to clinical commercialization. With vast expertise in the pre-clinical, clinical, and healthcare space, StemExpress knows the importance of moving projects through commercialization to…
For More InformationAARC Annual Meeting 2022
March 11, 2022 (NEW ORLEANS, LA) – StemExpress is excited to attend the AACR Annual Meeting, April 8-13, 2022, where we will join the innovative minds in the clinical space to discuss the importance of picking partners from product development to clinical commercialization. As more cancer therapies move through clinical approval, our company mission is…
For More InformationCEO & Founder Cate Dyer Discusses Cell & Gene Therapies with the Video Journal of Regenerative Medicine
Cate’s discussion focused on the importance of creating a closed-loop system for cell and gene clinical therapies by leveraging existing partnerships with hospital systems and the 8 U.S.-based StemExpress clinical collection centers within nearby proximity to industry-leading hospital systems.
For More Information